Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramod N Nehete

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2023
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaquesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2023
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Pharmaceutics|October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic ImplantFernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
The American Journal of Tropical Medicine and Hygiene|November 29, 2017
Experimental Zika Virus Infection of Neotropical PrimatesJohn A Vanchiere, Julio C Ruiz, Alan G Brady, et al.
Science Translational Medicine|June 28, 2023
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Advanced Therapeutics|May 17, 2021
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primatesFernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.
Nature Communications|December 26, 2022
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in ratsJesus Paez-Mayorga, Jocelyn Nikita Campa-Carranza, Simone Capuani, et al.
Nature Communications|March 10, 2026
CXCR4-tropic HIV-1 infection in an immunocompetent monkey modelNicholas R Meyerson, Vanessa L Bauer, Will T Fattor, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2023
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaquesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2023
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Pharmaceutics|October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic ImplantFernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
The American Journal of Tropical Medicine and Hygiene|November 29, 2017
Experimental Zika Virus Infection of Neotropical PrimatesJohn A Vanchiere, Julio C Ruiz, Alan G Brady, et al.
Science Translational Medicine|June 28, 2023
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Advanced Therapeutics|May 17, 2021
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primatesFernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.
Nature Communications|December 26, 2022
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in ratsJesus Paez-Mayorga, Jocelyn Nikita Campa-Carranza, Simone Capuani, et al.
Nature Communications|March 10, 2026
CXCR4-tropic HIV-1 infection in an immunocompetent monkey modelNicholas R Meyerson, Vanessa L Bauer, Will T Fattor, et al.
Pageof 6